Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02618148 · ClinicalTrials.gov registry record · Phase 4
Hormone Estradiol Replacement Therapy Additional Herbals
A Phase 4 study of Menopause, sponsored by Trieu, Nguyen Thi, M.D..
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 2
- Study locations
NCT02618148 is a Phase 4 study of Menopause that has completed, run by Trieu, Nguyen Thi, M.D.. The registered enrollment target is 60 participants, below the 9,393-participant average among 54 other Menopause trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT02618148, a Phase 4 study of Menopause, has completed, sponsored by Trieu, Nguyen Thi, M.D..
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine whether Hormone Replacement Therapy (HRT), safety studies are combined with herbal (garlic oil, rutin, and nattokinase) to reduce estrogen side effects. Making it safer when an endocrine supplement is needed for estrogen deficiency symptoms in menopausal and postmenopausal women.
Conditions Studied
Interventions
- DRUG ESTROGEN HERBALS 21
- DRUG ESTROGEN HERBALS 28
Study Locations (2)
Delaware
- Saigon Biopharma LLC - Wilmington
Other
- Saigon Biopharma Company Limited - Ho Chi Minh City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2009-01 |
| Est. Completion | 2015-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02618148
The ClinicalTrials.gov registry entry for NCT02618148 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,393-participant average among 54 other Menopause trials with a reported enrollment target (99% lower). The listed sponsor is Trieu, Nguyen Thi, M.D., which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Menopause appearing as the primary indexed condition, and to 2 interventions - of which ESTROGEN HERBALS 21 is the first listed.
NCT02618148 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Delaware, Other.
Frequently Asked Questions
What is clinical trial NCT02618148 about?
NCT02618148 is a clinical study titled "Hormone Estradiol Replacement Therapy Additional Herbals". The purpose of this study is to determine whether Hormone Replacement Therapy (HRT), safety studies are combined with herbal (garlic oil, rutin, and nattokinase) to reduce estrogen side effects. Making it safer when an endocrine supplement is needed for estrogen deficiency symptoms in menopausal and...
What is the current status of trial NCT02618148?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2009-01. Estimated completion is 2015-06.
What conditions does trial NCT02618148 study?
This clinical trial studies the following conditions: Menopause.
What interventions are being tested in trial NCT02618148?
The interventions under investigation include: ESTROGEN HERBALS 21 (DRUG), ESTROGEN HERBALS 28 (DRUG).
Who is sponsoring clinical trial NCT02618148?
This trial is sponsored by Trieu, Nguyen Thi, M.D., which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02618148 being conducted?
This trial has 2 study locations across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menopause
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cardiometabolic Consequences of the Loss of Ovarian Function
RECRUITING · Phase 4
-
Role of Menopause in Thermoregulation
RECRUITING · Phase 4
-
Efficacy of Suvorexant in the Treatment of Insomnia in Midlife Women With Pre-Diabetes
RECRUITING · Phase 4
-
Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study)
ACTIVE NOT RECRUITING · Phase 4
-
Effect of Nuvigil on Fatigue
COMPLETED · Phase 4
-
Brain Imaging Study in Menopausal Women With and Without Major Depressive Disorder
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.